Better Care, Everywhere
What if we could detect any pandemic, epidemic or bacterial resistance surge everywhere on the planet?
OUR PRODUCTS
Our molecular diagnostic kits are programmable toward any DNA or RNA pathogen.
Highly specific and sensitive (several peer-reviewed papers), they are easy to adopt with low barrier to implementation and a reduced footprint for on-site testing.
WHY EN CARTA
FAST PRODUCT DEVELOPMENT
Our development cycle is fast.
We quickly develop exactly the diagnostic you are looking for.
WE TAKE ACTION
Our action is embedded in the UN sustainable development goals 3, good health and 6, clean water and sanitation.
DEEP TECH
Our products leverage the most cutting-edge synthetic biology technologies for diagnostics development today.
LATEST PRODUCT
En Carta COVID-19 Diagnostic kit
Our technology powers a rapid, low cost and accurate COVID-19 diagnostic.
Detect up to 100 COVID-19 infections in 60 minutes with PCR-like accuracy using your plate-reader.
Our variants kit enable you to screen accurately the 5 main variants.
We hypothesize that diagnostics powered by cell-free systems can be used to make point-of-care nucleic acid diagnostics for HIV, TB, and HPV with specificity down to the single-nucleotide level and costs below $1.
These diagnostics will benefit from the extremely low cost of cell-free systems and be embedded within paper test strips to enable room temperature stability for up to a year